203 related articles for article (PubMed ID: 2250574)
1. The effect of serotonergic agents on haloperidol-induced catalepsy.
Hicks PB
Life Sci; 1990; 47(18):1609-15. PubMed ID: 2250574
[TBL] [Abstract][Full Text] [Related]
2. Serotonergic involvement in haloperidol-induced catalepsy.
Neal-Beliveau BS; Joyce JN; Lucki I
J Pharmacol Exp Ther; 1993 Apr; 265(1):207-17. PubMed ID: 8386235
[TBL] [Abstract][Full Text] [Related]
3. Central 5-HT(4) receptors and dopamine-dependent motor behaviors: searching for a functional role.
De Deurwaerdère P; Cervo L; Stinus L; Spampinato U
Pharmacol Biochem Behav; 2002 Apr; 71(4):627-33. PubMed ID: 11888554
[TBL] [Abstract][Full Text] [Related]
4. Effect of serotonergic agents on adenosine A2 receptor mediated catalepsy in mice.
Mandhane SN; Khisti RT; Chopde CT
Psychopharmacology (Berl); 1998 May; 137(2):113-9. PubMed ID: 9629997
[TBL] [Abstract][Full Text] [Related]
5. 5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy.
Prinssen EP; Colpaert FC; Koek W
Eur J Pharmacol; 2002 Oct; 453(2-3):217-21. PubMed ID: 12398907
[TBL] [Abstract][Full Text] [Related]
6. Effects of 5-HT in globus pallidus on haloperidol-induced catalepsy in rats.
Wei L; Chen L
Neurosci Lett; 2009 Apr; 454(1):49-52. PubMed ID: 19429052
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Zazpe A; Artaiz I; Innerárity A; Del Olmo E; Castro E; Labeaga L; Pazos A; Orjales A
Neuropharmacology; 2006 Jul; 51(1):129-40. PubMed ID: 16643965
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of chlorpromazine-induced catalepsy by the 5-HT-1A ligands pindolol and buspirone in mice.
Silva SR; Futuro-Neto HA; Pires JG
Braz J Med Biol Res; 1990; 23(9):869-71. PubMed ID: 2101330
[TBL] [Abstract][Full Text] [Related]
9. The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms.
Invernizzi RW; Garavaglia C; Samanin R
Neuropsychopharmacology; 2003 May; 28(5):872-9. PubMed ID: 12644843
[TBL] [Abstract][Full Text] [Related]
10. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
Ninan I; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
[TBL] [Abstract][Full Text] [Related]
11. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice.
Egashira N; Matsuda T; Koushi E; Mishima K; Iwasaki K; Shoyama Y; Fujiwara M
Eur J Pharmacol; 2006 Nov; 550(1-3):117-22. PubMed ID: 17022969
[TBL] [Abstract][Full Text] [Related]
12. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
13. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.
Haleem DJ; Shireen E; Haleem MA
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1323-9. PubMed ID: 15588759
[TBL] [Abstract][Full Text] [Related]
14. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
Kleven MS; Barret-Grévoz C; Bruins Slot L; Newman-Tancredi A
Neuropharmacology; 2005 Aug; 49(2):135-43. PubMed ID: 15996562
[TBL] [Abstract][Full Text] [Related]
15. Cataleptic effect of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice: modulation by serotonergic agents.
Deshpande LS; Khisti RT; Chopde CT
Brain Res; 2001 Apr; 898(1):13-26. PubMed ID: 11292445
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist.
Reavill C; Kettle A; Holland V; Riley G; Blackburn TP
Br J Pharmacol; 1999 Feb; 126(3):572-4. PubMed ID: 10188965
[TBL] [Abstract][Full Text] [Related]
17. Serotonergic modulation of extrapyramidal motor disorders in mice and rats: role of striatal 5-HT3 and 5-HT6 receptors.
Ohno Y; Imaki J; Mae Y; Takahashi T; Tatara A
Neuropharmacology; 2011; 60(2-3):201-8. PubMed ID: 20813116
[TBL] [Abstract][Full Text] [Related]
18. Involvement of presynaptic 5-HT
Mombereau C; Arnt J; Mørk A
Pharmacol Biochem Behav; 2017 Feb; 153():141-146. PubMed ID: 28057524
[TBL] [Abstract][Full Text] [Related]
19. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
Mignon L; Wolf WA
Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404
[TBL] [Abstract][Full Text] [Related]
20. Effects of local application of 5-hydroxytryptamine into the dorsal or median raphe nuclei on haloperidol-induced catalepsy in the rat.
Wadenberg ML; Young KA; Richter JT; Hicks PB
Neuropharmacology; 1999 Jan; 38(1):151-6. PubMed ID: 10193906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
